Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis

Clinical Journal of Pain

Volumn 23, Issue 6, 2007, Pages 511-517

  Shaladi, Alì ^a   Saltari, Maria Rita ^a   Piva, Bruno ^a   Crestani, Francesco ^a   Tartari, Stefano ^b   Pinato, Paolo ^c   Micheletto, Giuseppe ^d   Dall'Ara, Roberto ^e  

^a Ospedale S Maria della Misericordia   (Italy)

^b Hospital of the Delta   (Italy)

^c Ospedale Umberto I   (Italy)

^d Hospital of Dolo   (Italy)

^e Hospital Mater Salutes   (Italy)

Author keywords

Continuous intrathecal morphine infusion; Osteoporosis; Vertebral fracture

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; CODEINE; FENTANYL; KETOROLAC; LAXATIVE; MORPHINE; OPIATE; PARACETAMOL; TRAMADOL;

AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTINUOUS INFUSION; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; INFUSION PUMP; MALE; MOBILIZATION; NAUSEA; OSTEOPOROSIS; PAIN; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; SOMNOLENCE; URINE RETENTION; VERTEBRA FRACTURE; VISUAL ANALOG SCALE; VOMITING; WORK; WOUND HEALING; WOUND INFECTION;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHRONIC DISEASE; FEMALE; FENTANYL; HUMANS; INJECTIONS, SPINAL; MALE; MORPHINE; OSTEOPOROSIS; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; SPINAL FRACTURES;

EID: 34250753370     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/AJP.0b013e31806a23d4     Document Type: Article

References (51)

1. Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med. 1993;94:646-650.
2. World Health Organization WHO. Assessment of Fracture Risk and its Application to Screening Postmenopausal Osteoporosis: Report of a WHO Technical Report Series. Report 843. Geneva: WHO; 1994.
3. Orwoll ES, Klien RF. Osteoporosis in men. Endoc Rev. 1995;16:87-116.
4. Lips P. Epidemiology and predictors of fractures associated with osteoporosis. Am J Med. 1997;103:3S-8S.
5. National Osteoporosis Society. Menopause and Osteoporosis Therapy Manual 1993, updated 1997.
6. Ross PD. Clinical consequences of vertebral fractures. Am J Med. 1997;103(suppl):305-435.
7. Melton LJ, Kan SH, Frye MA, et al. Epidemiology of vertebral fractures in women. Am J Epidemiol. 1989;129:1000-1011.
8. Cummings SR, Tabor HK. The epidemiology of vertebral fractures. In: Genant HK, Jergas M, van Kuijk C, eds. Vertebral Fracture in Osteoporosis. San Francisco, Calif: Radiology Research and Education Foundation; 1995:3-14.
9. Sartori L, Busato F. Epidemiologia dell'osteoporosi. SYLLABUS sull'osteoporosi Ed. EDMES 2000:9-16.
10. Adami S, Glatt D, Rossini M. The radiological assessment of vertebral osteoporosis. Bone. 1992;13:33-36.
11. Cooper C. Epidemiology of vertebral fractures in Western populations. Spine State Art Rev. 1994;8:1-12.
12. Terrence H, Diamond MD, Bernard Champion MD. Management of acute osteoporotic vertebral fractures: a non randomised trial comparing percutaneous vertebroplasty with conservative therapy. Am J Med. 2003;114:257-265.
13. Ross PD, Davis JW. Pre-existing fractures and bone mass predict vertebral fracture incidence. Ann Intern Med. 1991;114:919-923.
14. Klozbecher CM, Ross PD, Landsmen PB, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721-739.
15. Leidig-Bruckner G, Minne HW, Sauer P, et al. A study of complaints and their relation to vertebral destruction in patients with osteoporosis. Bone Miner. 1990;8:217-229.
16. Young MH. Long term consequences of stabile fractures of the thoracic and lumbar vertebral bodies. J Bone Joint Surg Br. 1973;55:295-300.
17. Lukert BP. Vertebral compression fractures. How to manage pain, avoid disability. Geriatrics. 1994;49:22-26.
18. Leidig-Bruckner G, Minne HW, Schlaich C, et al. Clinical grading of spinal osteoporosis: QOL components and spinal deformity in women with chronic low back pain and with vertebral osteoporosis. J Bone Miner Res. 1997;12:663-675.
19. Krane SM, Holick MF. Metabolic bone disease. In: Fauci AS, Braunwald E, Isselbcher KJ, et al, eds. Harrison's Principles of Internal Medicine, International. 14th ed. New York: McGraw-Hill; 1998:2247-2259.
20. Ringe JD. Too many osteoporosis patients are undertreated with analgesics. Chronic pain promotes bone loss. MMW Fortschr Med. 2003;145:43-45.
21. Gagliese L, Melzakck R. Chronic pain in elderly people. Pain. 1997;70:3-14.
22. Adams PF. Health Statistics on Older Persons Living in the Community. Hyattsville, MD: US Public Health Service; 1987.
23. Wolfe MM, Lichensten DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999;340:1888-1889.
24. Silverman SL, Azria M. The analgesic role of calcitonin following osteoporotic fractures. Osteoporosis Int. 2002;13:858-867.
25. Ringe JD, Faber H, Bock O, et al. Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol Int. 2002;22:199-203.
26. Scott J, Huskisson EC. Graphic representation of pain. Pain. 1967;2:175-184.
27. Lips P, Cooper D, Agnusdei F, et al. QOL in patients with vertebral fractures: validation of the QOL questionnaire of the European foundation for osteoporosis (QUALEFFO). Osteoporosis Int. 1999;10:150-160.
28. Riggs BL, Melton LJ III. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995;17:505s-511s.
29. Follet KA, Hiltchon PW. Response of intractable pain to continuous intrathecal morphine. Pain. 1992;49:21-25.
30. Anderson CA, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic non-malignant pain. Neurosurgery. 1999;44:289-301.
31. Krames ES. Intraspinal opioid therapy for chronic non-malignant pain: current practice and clinical guidelines. J Pain Symptom Manage. 1996;11:333-352.
32. Krames ES. Implantable devices for pain control: spinal cord stimulation and intrathecal therapies. Best Practice Res. 2002;16:619-649.
33. Grados F, Depriester C, Cayrolle G, et al. Long term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Rheumatology. 2000;39:1410-1414.
34. Barr JD, Barr MS, Lemley TJ, et al. Percutaneous vertebroplasty for pain relief and spinal stabilization. Spine. 2000;25:923-928.
35. Cotten A, Boutry N, Cortet B, et al. Percutaneous vertebroplasty: state of the art. Radiographics. 1998;18:311-320.
36. Martin JB, Jean B, Sugiu K, et al. Vertebroplasty: clinical experience and follow-up results. Bone. 1999;25:11-15.
37. Kaufmann TJ, Jensen ME, Schweickert PA, et al. Age of fracture and clinical outcomes of percutaneous vertebroplasty. AJNR Am J Neuroradiol. 2001;22:1860-1863.
38. Harrington KD. Major neurological complications following percutaneous vertebroplasty with polymethylmethacrylate: a case report. J Bone Joint Surg Am. 2002;27:419-422.
39. Nussbaum DA, Gaillou P, Murphy K. A review of complications associated with vertebroplasty and kyphoplasty as reported to the Food and Drug Administration Medical Device Related Web Site. J Vasc Interv Radiol. 2004;15:1185-1192.
40. Crandall D, Slaughter D, Hankins PJ, et al. Acute versus chronic vertebral compression fractures treated with kyphoplasty early results. Spine. 2004;4:418-424.
41. Majd ME, Farley S, Holt RT. Preliminary outcomes and efficacy of the first 360 consecutive kyphoplasties for the treatment of painful osteoporotic vertebral compression fractures. Spine. 2005;5:244-255.
42. Gaitanis IN, Hadjipavlou AG, Katonis PG, et al. Balloon kyphoplasty for the treatment of pathological vertebral compressive fracture. Eur J Spine. 2005;14:250-260.
43. Yaksh TI, Onofrio BM. Retrospective consideration of the doses of morphine given intrathecally by chronic infusion in 163 patients by 19 physicians. Pain. 1987;31:211-223.
44. Winkelmuller M, Winkelmuller W. Long term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg. 1996;85:458-467.
45. Paice JA, Penn RD, Scott S. Intraspinal morphine for chronic pain: a retrospective multicenter study. J Pain Symptom Manage. 1996;11:71-80.
46. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long term benefits and efficacy. Surg Neurol. 2001;55:79-88.
47. Krames ES, Lanning RM. Intrathecal infusional analgesia for non malignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine. J Pain Symptom Manage. 1993;8:539-548.
48. Brazenor GA. Long term intrathecal administration of morphine: a comparison of bolus injection via reservoir with continuous infusion of implanted pump. Neurosurgery. 1987;21:484-491.
49. Saltuari L, Kronemberg J, Marosi MJ, et al. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity. Acta Neurol (Napoli). 1992;14:187-194.
50. Moulin DE, Leezzi A, Amireh R, et al. A randomised trial of oral morphine for chronic non-cancer pain. Lancet. 1996;347:143-147.
51. World Health Organisation Cancer Pain Relief 2nd ed. 1989. Geneva: World Organisation.